Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
Inhibitory killer cell immunoglobulin receptors (KIR) bind to major histocompatibility complex antigens. Concise knowledge of KIR ligands allows prediction of natural killer (NK)-cell alloreactivity after hematopoietic stem cell transplantation. KIR3DL1 binds to the Bw4 epitope on HLA-B antigens. Although the same epitope is also found on 4 HLA-A antigens (HLA-A23/24/25/32), these are not currently regarded as KIR3DL1 ligands. We show that expression of HLA A*2301, A*2402, or A*3201 but not HLA A*2501 protects target cells from lysis by KIR3DL1(+) NK cells. KIR3DL1(+) NK cells from donors expressing the Bw4 epitope on an HLA-A antigen only are fully functional and capable of lysing Bw4(-) target cells. HLA A25 differs at amino acid 90, close to the serologic Bw4 epitope, from A23/24/32 and from Bw4(+) HLA-B antigens. These data suggest that HLA-A antigens should be taken into consideration when assessing the potential for NK alloreactivity after hematopoietic stem cell transplantation.
Stern
Martin
M
Department of Hematology, University Hospital Basel, Basel, Switzerland. sternm@uhbs.ch
Ruggeri
Loredana
L
Capanni
Marusca
M
Mancusi
Antonella
A
Velardi
Andrea
A
D003602:Cytotoxicity, Immunologic; D015234:HLA-A Antigens / Q000378:metabolism*; D059871:HLA-A24 Antigen; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D008024:Ligands; D054341:Receptors, KIR3DL1 / Q000378:metabolism*; D014181:Transplantation Immunology
D015234:HLA-A Antigens; C084028:HLA-A*23 antigen; C037019:HLA-A*25 antigen; C531148:HLA-A*32 antigen; D059871:HLA-A24 Antigen; D008024:Ligands; D054341:Receptors, KIR3DL1